produce hypercalcaemia in a normal patient. I now summarize some data for our fifteen hypercalcaemic sarcoid patients, which includes that of our first five published already (Dent, 1958) (Dent & Watson, 1968) . Further studies of this calcium abnormality at U.C.H. (Anderson et al., 1954) We are still puzzled as to the possible mechanism by which the chronic sarcoid granuloma sometimes produces this sensitization to vitamin D, but current work on its metabolism sugges,s possible explanations. We now know that vitamin D has to be converted to 25-hydroxycholecalciferol before it can exert its usual action (Blunt, De Luca & Schnoes, 1968) . In some cases of so called 'vitamin D resistance' (for instance in renal failure) this conversion is somehow inhibited (Avioli et al., 1968 Fig. 2 ). All these patients were found to have parathyroid adenomas as well, which when removed dealt with the hypercalcaemia adequately, thus showing that the adenoma was the entire cause in these patients. I believe that finding three such patients in our series is likely to be more than a coincidence and am speculating that sarcoidosis may sometimes stimulate the parathyroid glands by an unknown mechanism to produce adenomas. If this is confirmed there will be yet another metabolic complication to add to that of the vitamin D sensitivity and it is interesting to wonder if there may be some link between these two.
